There are also studies showing that HSP27 levels in serum and in TME were significantly higher in both PC and breast cancer patients, whereas low level of HSP27 was associated with nonresponsiveness to chemotherapy treatment, suggesting that HSP27 could be used as a biomarker for the diagnosis of certain human cancer.271, 272. This evidence concerns the gene HSPB3 and pachyonychia congenita.